Summary
Catheter-based renal artery denervation appears to result in sustained blood pressure (BP) reduction with a favorable safety profile in patients through 3 years with consistent benefit across age, diabetes status, and renal function. This article presents the final 3-year results from the Renal Denervation in Patients With Refractory Hypertension trial [Symplicity HTN-1; NCT00664638].
- Hypertensive Disease
- Renal Disease
- Hypertension & Kidney Disease
- Cardiology Clinical Trials
- Interventional Radiology
- Hypertensive Disease
- Cardiology & Cardiovascular Medicine
- Renal Disease
- Hypertension & Kidney Disease
- Cardiology Clinical Trials
- Interventional Radiology
- © 2013 MD Conference Express®
Tools
Catheter-Based Renal Artery Denervation – Sustained Blood Pressure Lowering with Reassuring Safety at 3 Years
Permalink:
Table of contents
Cited By...
- No citing articles found.